Both in Pharmaceuticals
Assembly Biosciences vs MapLight Therapeutics
Over the past year ASMB returned −35.9% and MPLT returned −60.6%; their daily moves had a correlation of 0.11.
ASMB −35.9% MPLT −60.6%Growth of $1, one year, split-adjusted
| Metric | ASMB | MPLT |
|---|---|---|
| Price | $19.97 | $6.67 |
| Market cap | $406.6M | $370.4M |
| Today | +0.25% | −2.13% |
| 1 month | −10.0% | −31.2% |
| 6 months | −36.3% | −77.0% |
| Year to date | −41.3% | −62.1% |
| 1 year | −35.9% | −60.6% |
| Revenue growth (YoY) | +38.9% | — |
| Gross margin | 100.0% | — |
| Net margin | −28.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.4× | — |
| Net cash | $320.4M | $304.7M |
| Dividend yield | — | — |
| Volatility (60d) | 63.6% | 61.1% |
| Short % of float | 28.0% | 24.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).